Literature DB >> 26855040

In vitro activity of Sorghum bicolor extracts, 3-deoxyanthocyanidins, against Toxoplasma gondii.

Daniel A Abugri1, William H Witola2, Jesse M Jaynes3, Nashar Toufic4.   

Abstract

We investigated dried red leaf extracts of Sorghum bicolor for activity against Toxoplasma gondii tachyzoites. S. bicolor red leaf extracts were obtained by bioassay-guided fractionation using ethanol and ethyl acetate as solvents. Analysis of the crude and fractionated extracts from S. bicolor using electrospray ionization mass spectrometry (ESI-MS) showed that they contained significant amounts of apigeninidin, luteolinidin, 7-methoxyapigeninidin, 5-methoxyapigeninidin, 5-methoxyluteolinidin, 7-methoxyluteolinidin 5,7-dimethoxyapigeninidin or 5,7-dimethoxyluteolinidin, based on mass per charge (m/z). When tested in vitro, the IC50s for inhibitory activity against T. gondii tachyzoites' growth of the ethanol and ethyl acetate extracts were 2.3- and 4-fold, respectively, lower than their cytotoxic IC50s in mammalian cells. Ethyl acetate extracts fractionated in chloroform-methanol and chloroform had IC50s against T. gondii that were 56.1- and 3-fold lower than their respective cytotoxic IC50s in mammalian cells. These antiparasitic activities were found to be consistent with those of the respective pure 3-deoxyanthocyanidin compounds identified to be contained in the fractions in significant amounts. Further, we observed that, the position and number of methoxy groups possessed by the 3-deoyanthocyanidins influenced their antiparasitic activity. Together, our findings indicate that S. bicolor red-leaf 3-deoxyanthocyanidins-rich extracts have potent in vitro inhibitory activity against the proliferative stage of T. gondii parasites.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  3-Deoxyanthocyanidins extracts; Antiparasitic compounds; Sorghum bicolor; Toxoplasma gondii

Mesh:

Substances:

Year:  2016        PMID: 26855040     DOI: 10.1016/j.exppara.2016.02.001

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  7 in total

1.  In vitro antagonistic and indifferent activity of combination of 3-deoxyanthocyanidins against Toxoplasma gondii.

Authors:  Daniel A Abugri; William H Witola; Jesse M Jaynes
Journal:  Parasitol Res       Date:  2017-10-30       Impact factor: 2.289

2.  Apigeninidin-enriched Sorghum bicolor (L. Moench) extracts alleviate Aflatoxin B1-induced dysregulation of male rat hypothalamic-reproductive axis.

Authors:  Solomon E Owumi; Moses T Otunla; Uche O Arunsi; Adegboyega K Oyelere
Journal:  Exp Biol Med (Maywood)       Date:  2022-06-06

Review 3.  The Experimental Role of Medicinal Plants in Treatment of Toxoplasma gondii Infection: A Systematic Review.

Authors:  Kourosh Cheraghipour; Leila Masoori; Behrooz Ezzatpour; Mona Roozbehani; Ali Sheikhian; Vahid Malekara; Massumeh Niazi; Omid Mardanshah; Kobra Moradpour; Hossein Mahmoudvand
Journal:  Acta Parasitol       Date:  2020-11-06       Impact factor: 1.440

4.  Interaction of apigenin-7-O-glucoside with pyrimethamine against Toxoplasma gondii growth.

Authors:  Daniel A Abugri; William H Witola
Journal:  J Parasit Dis       Date:  2019-12-02

5.  Vernonia calvoana Shows Promise towards the Treatment of Ovarian Cancer.

Authors:  Ariane T Mbemi; Jennifer N Sims; Clement G Yedjou; Felicite K Noubissi; Christian R Gomez; Paul B Tchounwou
Journal:  Int J Mol Sci       Date:  2020-06-22       Impact factor: 5.923

6.  Anti-Toxoplasma activity of Sorghum bicolor-derived lipophilic fractions.

Authors:  Daniel A Abugri; Jesse M Jaynes; William H Witola
Journal:  BMC Res Notes       Date:  2019-10-24

7.  Evaluation of Immunotropic Activity of Iridoid-Anthocyanin Extract of Honeysuckle Berries (Lonicera caerulea L.) in the Course of Experimental Trichinellosis in Mice.

Authors:  Jolanta Piekarska; Marianna Szczypka; Michał Gorczykowski; Anna Sokół-Łętowska; Alicja Z Kucharska
Journal:  Molecules       Date:  2022-03-17       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.